Inovação social apesar da propriedade intelectual: o caso da iniciativa medicamentos para doenças negligenciadas

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Universidade Federal de Juiz de Fora (UFJF)

Abstract

This article aims to understand how the intellectual property (IP) and open innovation policies of the Drugs for Neglected Diseases Initiative (DNDi) are implemented, assessing the role played by IP in the productive development partnerships promoted by the initiative, as well as its impact on this form of social pharmaceutical innovation. Guided by the documentary analysis method and Yin's formulations for case studies, an empirical study was conducted with a qualitative approach. By analyzing sources such as clauses in the Research and Development partnership model contracts of DNDi, it is possible to infer that the initiative's institutional model offers a middle ground between adopting exclusive legislation and having no protection at all, occupying an intermediate zone that balances the tensions between Law and Love observed by Bankowski. However, this study demonstrates that the reasons why DNDi continues to use the IP institute still need to be clarified. Furthermore, it demonstrates how DNDi's IP policy and its efforts in open innovation collaborations bring it closer to an institutional-reciprocal model of welfare linked to social innovation.

Description

Citation

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwise noted, this item's license is described as Acesso Aberto